Speak with your doctor about Voltaren® Gel
Osteoarthritis joint pain doesn’t have to control your life
OA is a chronic condition that can cause persistent joint pain. But the pain of osteoarthritis can be treated. With a serious commitment and proper treatment, you may be able to keep OA joint pain from interfering in your life.
If you are currently treating OA but still experiencing joint pain, ask yourself the
following questions:
- Have you tried nonprescription medications to deal with OA joint pain? How often are you using them?
- Are you still experiencing OA joint pain, despite taking nonprescription medication?
- Are you concerned about taking another oral medication?
- Are you already rubbing and massaging your joints for OA joint pain relief?
If you answered Yes to some of these questions, you should ask your doctor if Voltaren Gel would be right for you.
Questions to ask your doctor
If you’re interested in asking your doctor about prescription Voltaren Gel, it may help to have some questions ready beforehand. To help you get started, try using the questions below. Feel free to print out this page and bring the questions with you the next time you see your doctor.
- What is Voltaren Gel? How is it different from other osteoarthritis pain relievers?
- Has the FDA approved any other prescription topical NSAIDs for the relief of OA joint pain?
- What are the medical guidelines? Should I use Voltaren Gel before trying
other medications? - Why was Voltaren Gel developed?
After discussing Voltaren Gel with your doctor, the two of you will be better able to decide whether Voltaren Gel is the right OA joint pain reliever for you.
Ask your doctor about Voltaren Gel today.
For U.S. Only
 To a friend |
|
 Add this page to your Facebook |
|
 Twitter this page |
|
 Digg this page |
|
 Add as a Del icio us bookmark |
|
 StumbleUpon this page |
Important Safety Information
*Voltaren® Gel is indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment, such as the knees and those of the hands. Voltaren Gel has not been evaluated for use on the spine, hip, or shoulder.
Cardiovascular Risk
- Nonsteroidal anti-inflammatory drugs (NSAIDs) may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk [see Warnings and Precautions].
- Voltaren Gel is contraindicated for the treatment of perioperative pain in the setting of coronary artery bypass graft (CABG) surgery [see Contraindications].
Gastrointestinal Risk
- NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events [see Warnings and Precautions].
The most common adverse reactions reported in Voltaren Gel clinical trials were application site reactions in 7% of treated patients. With all NSAIDs there may be an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal.
The use of Voltaren Gel is contraindicated in patients with a known hypersensitivity to diclofenac.
Voltaren Gel should not be administered in patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients.
Voltaren Gel should not be used in combination with other oral NSAIDs or aspirin because of the potential for increased adverse effects. Similarly, combined use of Voltaren Gel with other topical products, such as sunscreens and cosmetics, on the same skin area has not been tested and should be avoided because of the potential to alter local tolerability and absorption.
There is a potential for elevation in liver function tests during treatment with diclofenac containing products.
Safety and effectiveness in pediatric patients have not been established.
Please see full Prescribing Information for Warnings and Contraindications.
